Is eczema communicable
Pro Research Analysisby 
Searched over 200M research papers
Is Eczema Communicable?
Understanding Eczema: A Non-Communicable Disease
Eczema, also known as atopic dermatitis, is a prevalent inflammatory skin condition that significantly impacts the quality of life of those affected. It is crucial to understand that eczema is classified as a non-communicable disease, meaning it cannot be transmitted from one person to another through direct contact or other means Ring2019Ring2015Zink2019+1 MORE.
Clinical Characteristics and Types of Eczema
Eczema manifests through various clinical signs such as redness, scaling, oozing, crusting, lichenification, and intense itching. Dermatohistological features include acanthosis, parakeratosis, spongiosis, and lymphocytic infiltrates . Eczema can be categorized into several types based on its etiology and location, including contact eczema, atopic eczema, seborrheic eczema, and nummular eczema .
Pathophysiology and Immune Response
The pathophysiology of eczema involves a disturbed skin barrier and an aberrant immune response. Recent advances in molecular genetics and lymphocyte immunology have provided deeper insights into these mechanisms. Eczema is characterized by an impaired epidermal barrier, increased susceptibility to infections, and the presence of eosinophils . Despite these advances, there remains a gap between understanding these mechanisms and effectively managing the disease in clinical practice Ring2019Ring2015.
Socioeconomic Impact
Eczema not only affects the physical health of individuals but also imposes a significant socioeconomic burden. Patients with eczema incur substantial out-of-pocket expenses for healthcare, including costs for emollients, moisturizers, medications, and medical consultations. These costs are higher compared to other chronic diseases, highlighting the economic strain on affected individuals .
Conclusion
In summary, eczema is a non-communicable inflammatory skin disease with complex pathophysiology and significant socioeconomic impact. It is not contagious and cannot be spread from person to person. Understanding its clinical characteristics, immune response patterns, and the financial burden on patients is essential for effective management and support for those affected.
Sources and full results
Most relevant research papers on this topic
Atopic eczema: burden of disease and individual suffering – results from a large EU study in adults
Atopic eczema affects 1-5 percent of adults in Europe, impairing quality of life and often goes unrecognized for its true impact on individual suffering.
Out-of-pocket Costs for Individuals with Atopic Eczema: A Cross-sectional Study in Nine European Countries.
Atopic eczema patients in Europe face a substantial burden of out-of-pocket costs, with emollients and moisturizers being the highest monthly costs.
Eczema vaccinatum.
Eczema vaccinatum (EV) is a potential smallpox vaccination complication in individuals with eczema/atopic dermatitis, causing extensive rash and systemic illness.
DOI
Severe eczema vaccinatum in a household contact of a smallpox vaccinee.
This case highlights the need for careful screening before smallpox vaccination and awareness of potential severe adverse events related to vaccinia virus.
DOI